The Inovalon Medical Outcomes Research for Effectiveness and Economics Registry (MORE² Registry®) is a data warehouse that empowers informed insight into national and regional healthcare trends, such as hospital utilization, medication adherence, chronic disease prevalence, and treatment effectiveness.
Features of this online resource describing population healthcare databases include:
- Searching by keyword / criteria
- Comparing and reviewing results
- Saving & exporting search results
We are happy to announce four new IQVIA profiles in our resource, including from 3 more countries!
Cerner Enviza's Auditron (Brazil) comprises of oncology patients with information regarding chemotherapy, target therapy, and radiotherapy claims since 2003. Auditron is fed by the private health insurances with anonymized patients’ information regarding diagnosis (histology, staging and mutations), treatment (including chemotherapy / systemic regimens, treatment duration, doses, cycles), and epidemiology data.
Send them a link to our latest tri-fold brochure which (1) lists the reasons why they should consider subscribing to our resource, (2) a summary of what’s included as part of their special access, (3) a complete list of the 45 countries we have database profiles and registries from, (4) along wit
We just updated the 10 IQVIA Oncology Dynamics database profiles in our resource (China, France, Germany, Italy, Japan, Mexico, Saudi Arabia, South Korea, Spain, and UK.) In the process, we uploaded 4 new ones from Belgium, Brazil, Bulgaria, and Romania.
Does your company routinely use population healthcare databases? There are hundreds available and deciding on the correct one for your needs may be difficult. Subscribe to B.R.I.D.G.E.
The IBM® MarketScan® Dental Database is a patient-level linked dental and medical insurance claims database that contains ~28.6 million covered lives. Established in 2005, this database is used for longitudinal and comparative analyses of diseases, treatment patterns, costs, duration of therapy, concomitant therapies, and other research purposes.